Tag Archives: ip

In Re Hubbell

Posted on March 20, 2013 by Warren Woessner

Guest post by Theresa Stadheim of Schwegman Lundberg & Woessner) In In Re Jeffrey Hubbell, Jason Schense, Andreas Zisch, and Heike Hall, Appeal No. 2011-1547 (Fed. Cir. March 7, 2013) (a copy can be found at the end of this post), … Continue reading →

Posted in Double Patenting | Tagged biotechnology, biotechnology law, BPAI, Double Patenting, Federal Circuit, Hubbell, intellectual property, ip, Patent Law, patents, theresa Stadheim, Warren Woessner | Leave a comment

UK National Stem Cell Network Report – The Patent Watch Landscape

Posted on March 7, 2013 by Warren Woessner

If you have either a passing or passionate interest in stem cell patenting, this report is worth some of your time. (A link to the report can be found at the end of this post.) The report analyzes the stem … Continue reading →

Posted in Stem Cells/Cloning | Tagged biotechnology, biotechnology law, biotechnology news, EPO, intellectual property, ip, IP law tools, PCT, stem cells, Warren Woessner | Leave a comment

Brilliant Instruments v. GuideTech – Doctrine of Equivalents on Review

Posted on February 21, 2013 by Warren Woessner

Contributed by Theresa Stadheim of Schwegman Lundberg & Woessner In Brilliant Instruments, Inc., v. Guidetech, LLC, Appeal no. 2012-1018 (Fed. Cir. February 20, 2013) (a copy can be found at the end of this post), a panel of the Federal … Continue reading →

Posted in Claim Interpretation, Doctrine of Equivalents | Tagged brilliant instruments, Federal Circuit, Guidetech, intellectual property, ip, Patent Law, patents, theresa Stadheim, Warren Woessner | Leave a comment

Time For Myriad To Fight Another Day

Posted on February 4, 2013 by Warren Woessner

Put another way, it is time for Jones Day to click their well-polished heels and go home. Today, the U.S. Government filed an amicus brief largely supporting the arguments by AMP/ACLU that isolated DNA is essentially the same molecule after … Continue reading →